Cited by 889Cancer therapeutics and mechanismsBioactive Compounds and Antitumor AgentsMetal complexes synthesis and properties

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II

Open access

Tewey, K M, Chen, G L, Nelson, E M, Liu, L F·1984·Journal of Biological Chemistry

DOI 10.1016/s0021-9258(17)47282-6

Open this paper in CoChat — free account

Abstract

Many intercalative antitumor drugs have been shown to induce reversible protein-linked DNA breaks in cultured mammalian cells. Using purified mammalian DNA topoisomerase II, we have demonstrated that the antitumor drugs ellipticine and 2-methyl-9-hydroxyellipticine (2-Me-9-OH-E+) can produce reversible protein-linked DNA breaks in vitro. 2-Me-9-OH-E+ which is more cytotoxic toward L1210 cells and more active against experimental tumors than ellipticine is also more effective in stimulating DNA cleavage in vitro. Similar to the effect of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) on topoisomerase II in vitro, the mechanism of DNA breakage induced by ellipticines is most likely due to the drug stabilization of a cleavable complex formed between topoisomerase II and DNA. Protein denaturant treatment of the cleavable complex results in DNA breakage and covalent linking of one topoisomerase II subunit to each 5'-end of the cleaved DNA. Cleavage sites on pBR322 DNA produced by ellipticine or 2-Me-9-OH-E+ treatment mapped at the same positions. However, many of these cleavage sites are distinctly different from those produced by the antitumor drug m-AMSA which also targets at topoisomerase II. Our results thus suggest that although mammalian DNA topoisomerase II may be a common target of these antitumor drugs, drug-DNA-topoisomerase interactions for different antitumor drugs may be different.

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(17)47282-6

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

DNA Topoisomerases
Gellert, M. F. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.004311 · Cited by 990
DNA Gyrase and the Supercoiling of DNA
Cozzarelli, N. R. (1980) · Science · doi:10.1126/science.6243420 · Cited by 720
DNA Modification and Cancer
Waring, M. J. (1981) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.50.070181.001111 · Cited by 690
The Anticancer Agent Adriamycin Can Be Actively Cytotoxic Without Entering Cells
Triton, T. R., & Yee, G. K. (1982) · Science · doi:10.1126/science.7089561 · Cited by 573
Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
Nelson, E. M., Tewey, K. M., & Liu, L. F. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.5.1361 · Cited by 561
Self-citation
Cleavage of DNA by mammalian DNA topoisomerase II.
Liu, L. F., Rowe, T. C., Yang, L., Tewey, K. M., & Chen, G. L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43815-4 · Cited by 534
Self-citation
Type II DNA topoisomerases: enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break.
Liu, L. F., Liu, C.-C., & Alberts, B. (1980) · Cell · doi:10.1016/s0092-8674(80)80046-8 · Cited by 486
Self-citation
Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino)methanesulfon-m-anisidide and adriamycin
Zwelling, L. A., Michaels, S., Erickson, L. C., Ungerleider, R. S., Nichols, M., & Kohn, K. W. (1981) · Biochemistry · doi:10.1021/bi00526a006 · Cited by 374
A homogeneous type II DNA topoisomerase from HeLa cell nuclei.
Miller, K. G., Liu, L. F., & Englund, P. T. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52552-2 · Cited by 359
Self-citation
Terminal stages of SV40 DNA replication proceed via multiply intertwined catenated dimers
Sundin, O. H., & Varshavsky, A. J. (1980) · Cell · doi:10.1016/0092-8674(80)90118-x · Cited by 354

Show all 39 references

Research works printed but not linked: 3

Zwelling, 1982, Cancer Res., 42, 2687
Burr-Furlong, 1978, Cancer Res., 38, 1329
Pommier, 1982, Biochem. Biophys. Res. Commun., 77, 1150

Sorted by citations

Items 601–700 of 889

Stimulation of Site-Specific Topoisomerase II-Mediated DNA Cleavage by an N-Methylpyrrolecarboxamide-anilinoacridine Conjugate: Relation to DNA Binding
Fosse, P., René, B., Saucier, J.-M., Hénichart, J., Waring, M. J., Colson, P., Houssier, C., & Bailly, C. (1994) · Biochemistry · doi:10.1021/bi00199a007 · Cited by 16
Differential Stabilization of Topoisomerase‐II–DNA Cleavable Complexes by Doxorubicin and Etoposide in Doxorubicin‐Resistant Rat Glioblastoma Cells
Montaudon, D., Pourquier, P., Denois, F., de Tinguy-Moreaud, E., Lagarde, P., & Robert, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00307.x · Cited by 16
Synthesis and In Vitro Cytotoxicity Evaluation of Novel Naphthindolizinedione Derivatives
Defant, A., Guella, G., & Mancini, I. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200600160 · Cited by 16
Differential protective effects of varying degrees of hypoxia on the cytotoxicities of etoposide and bleomycin
Yamauchi, T., Raffin, T. A., Yang, P. C.-M., & Sikic, B. I. (1987) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00261473 · Cited by 16
Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia
Guérin, É., Entz‐Werlé, N., Eyer, D., Pencreach, E., Schneider, A., Falkenrodt, A., Uettwiller, F., Babin, A., Voegeli, A.-C., Lessard, M., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402774 · Cited by 16
Etoposide-induced PC12 cell death: apoptotic morphology without oligonucleosomal DNA fragmentation or dependency upon de novo protein synthesis
Saura, J., MacGibbon, G. A., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00105-8 · Cited by 16
Enhancement of heat-induced heat shock protein (hsp)72 accumulation by doxorubicin (Dox) in vitro
Ohtsuboa, T., Kanob, E., Uedac, K., Matsumotob, H., Saitoa, T., Hayashib, S., Hatashitab, M., Jinb, Z.-H., & Saitoa, H. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00528-0 · Cited by 16
ED‐110, a Novel Indolocarbazole, Prevents the Growth of Experimental Tumors in Mice
Arakawa, H., Iguchi, T., Yoshinari, T., KOJIRI, K., Suda, H., & Okura, A. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb00178.x · Cited by 16
Optimization of Human Neural Progenitor Cells for an Imaging-Based High-Throughput Phenotypic Profiling Assay for Developmental Neurotoxicity Screening
Culbreth, M. E., Nyffeler, J., Willis, C. M., & Harrill, J. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2021.803987 · Cited by 15
Nkx3.1 controls the DNA repair response in the mouse prostate
Zhang, H., Zheng, T., Chua, C. W., Shen, M. M., & Gelmann, E. P. (2015) · The Prostate · doi:10.1002/pros.23131 · Cited by 15
“DNA crosslink damage has to involve both strands of DNA and may utilize more than one DNA repair pathway including nucleotide excision repair (NER) and homology-directed DNA repair [12,13].”
Background
Design, synthesis and biological evaluation of 1,3-diphenylbenzo[f][1,7]naphthyrdines
Arepalli, S. K., Park, B., Lee, K., Jo, H., Jun, K.-Y., Kwon, Y., Kang, J. S., Jung, J., & Lee, H. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.030 · Cited by 15
Interrelationship between affinity for DNA, cytotoxicity and induction of DNA-breaks in cultured L1210 cells for two series of tricyclic intercalators
Pierson, V., Pierré, A., COINTET, P. D., Nguyen, C.-H., Bisagni, É., & Gros, P. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90178-0 · Cited by 15
Stimulation by γ-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II
Fossé, P., René, B., Saucier, J.-M., Nguyen, C. H., Bisagni, É., & Paoletti, C. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90144-a · Cited by 15
The effects of ICRF-154 in combination with other anticancer agents in vitro
Kano, Y., Narita, T., Suzuki, K., Akutsu, M., Suda, K., Sakamoto, S., & Miura, Y. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.257 · Cited by 15
Characterization of an etoposide-resistant human ovarian cancer cell line
Kubota, N., Nishio, K., Takeda, Y., Ohmori, T., Funayama, Y., Ogasawara, H., Ohira, T., Kunikane, H., Terashima, Y., & Saijo, N. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685075 · Cited by 15
Binding Site for Ethidium Cation in the Major Groove of B-Form DNA
Monaco, R. R., & Hausheer, F. H. (1993) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1993.10507999 · Cited by 15
GCP, a genistein-rich compound, inhibits proliferation and induces apoptosis in lymphoma cell lines
McCall, J. L., Burich, R. A., & Mack, P. C. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.03.025 · Cited by 15
Inhibition of Epstein-Barr-virus-transformed human chronic lymphocytic leukaemic B cells with monoclonal-antibody-Adriamycin (doxorubicin) conjugates
Zhu, Z., Kralovec, J. A., GHOSE, T., & Mammen, M. (1995) · Cancer Immunology Immunotherapy · doi:10.1007/bf01519900 · Cited by 15
Preferential inhibition of DNA polymerases?,?, and? from Novikoff hepatoma cells by inhibitors of cell proliferation
Fox, G., Popanda, O., Edler, L., & Thielmann, H. W. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01226265 · Cited by 15
Inhibition of Pea Chloroplast DNA Helicase Unwinding and ATPase Activities by DNA-Interacting Ligands
Tuteja, N., & Phan, T.-N. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8363 · Cited by 15
The in vitro involvement of topoisomerase II in the activity of aza-ellipticine analogues is not correlated with drug activity on isolated nuclei
Vilarem, M., Riou, J., Multon, É. T., Gras, M.-P., & Larsen, C. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90575-7 · Cited by 15
Effect of ionizing radiation and topoisomerase II inhibitors on DNA synthesis in mammalian cells
LALLEV, A., Anachkova, B., & Russev, G. C. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18130.x · Cited by 15
L-Asparaginase, Doxorubicin, Vincristine, and Prednisolone (LHOP) Chemotherapy as a First-Line Treatment for Dogs with Multicentric Lymphoma
Lee, J. J., Liao, A. T., & Wang, S. L. (2021) · Animals · doi:10.3390/ani11082199 · Cited by 14
Antimalarial and cytotoxic activities of roots and fruits fractions of Astrodaucus persicus extract.
Goodarzi, S., Nateghpour, M., Asgharian, P., Hadjiakhoondi, A., Yassa, N., Tavakoli, S., Mirzaei, J., Farivar, L., Haghi, A. M., & Tofighi, Z. (2017) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.9554 · Cited by 14
Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs
Galán, A., Nedev, H., Bijian, K., Su, J., Alaoui‐Jamali, M. A., & Saragovi, H. U. (2012) · Oncogene · doi:10.1038/onc.2012.283 · Cited by 14
Sertoli Cell Morphological Alterations in Albino Rats Treated with Etoposide during Prepubertal Phase
Stumpp, T., Freymüller, E. H., & Miraglia, S. M. (2008) · Microscopy and Microanalysis · doi:10.1017/s1431927608080318 · Cited by 14
Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors
Arepalli, S. K., Lee, C., Sim, S., Lee, K., Jo, H., Jun, K.-Y., Kwon, Y., Kang, J. S., Jung, J.-K., & Lee, H. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.09.019 · Cited by 14
Decreased resistance toN,N-dimethylated anthracyclines in multidrug-resistant Friend erythroleukemia cells
Schaefer, A., Westendorf, J., Lingelbach, K. R., Schmidt, C. A., Mihalache, D.-L., Reymann, A., & Marquardt, H. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685675 · Cited by 14
“The mechanism of their cytostatic action is attributed mainly to DNA intercalation, but other biochemical properties such as the generation of highly reactive free radicals [1, 19, 22], interaction with topoisomerase II [48, 49], and binding to membrane structures [20, 43] have also been discussed in anthracycline-ind…”
Background
Etoposide- and BMY-40481-Induced Sensory Neuropathy in Mice
Bregman, C. L., Buroker, R. A., Hirth, R. S., Crosswell, A. R., & Durham, S. K. (1994) · Toxicologic Pathology · doi:10.1177/019262339402200508 · Cited by 14
Role of an Inverted CCAAT Element in Human Topoisomerase IIα Gene Expression in ICRF-187-Sensitive and -Resistant CEM Leukemic Cells
Morgan, S. E., & Beck, W. T. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12828-3 · Cited by 14
The p53 Tumor Suppressor Stimulates the Catalytic Activity of Human Topoisomerase IIα by Enhancing the Rate of ATP Hydrolysis
Kwon, Y. V., Shin, B. S., & Chung, I. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002081200 · Cited by 14
Evaluation of teniposide (VM-26)-induced toxicity on mouse spermatogenesis by flow cytometry
Jyothi, P. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00394-8 · Cited by 14
High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy
Zhang, H., Zhao, Y., Liu, X., Fu, L., Gu, F., & Ma, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.724250 · Cited by 13
“As well as known, anthracyclines interfere at the interface of Topo II-DNA with their sugar moieties and the cyclohexane ring A, which ultimately results in enzyme-mediated DNA damage in the form of double strand break (DSB) (14, 15).”
Background
Effects of an unusual poison identify a lifespan role for Topoisomerase 2 in Saccharomyces cerevisiae
Tombline, G., Millen, J. I., Polevoda, B. V., Rapaport, M., Baxter, B. K., Meter, M. V., Gilbertson, M. A., Madrey, J., Piazza, G. A., Rasmussen, L. A., et al. (2017) · Aging · doi:10.18632/aging.101114 · Cited by 13
“Thus fob1 Δ cells are resistant to the lifespan shortening effects of SIR2 deletion and NAM [24].”
Influential
Activity of New Synthetic (2-Chloroethylthio)-1,4-naphthoquinones in Prostate Cancer Cells
Dyshlovoy, S. A., Pelageev, D. N., Jakob, L. S., Borisova, K. L., Hauschild, J., Busenbender, T., Kaune, M., Khmelevskaya, E. A., Graefen, M., Bokemeyer, C., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14100949 · Cited by 13
“Additionally, p53-independent cancer cell death [16] and inhibition of topoisomerase II enzyme have been observed [17,18].”
Background
Tests of posterior pituitary function
Ball, S. G., Barber, T. M., & Baylis, P. H. (2003) · PubMed · doi:10.82444/warw.33788002 · Cited by 13
Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in Neurospora crassa
Gupta, R. (1990) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(90)90007-o · Cited by 13
Multidrug resistance in leukaemia
Baines, P., Cumber, P. M., & Padua, R. A. (1992) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(11)80053-3 · Cited by 13
Antitumor agents—CLI. Bis(helenalinyl)glutarate and bis(isoalantodiol-B)glutarate, potent inhibitors of human DNA topoisomerase II
Chen, C.-H., Yang, L., Lee, T. T.-Y., Shen, Y., Zhang, D.-C., Pan, D.-J., McPhail, A. T., McPhail, D. R., Liu, S.-Y., Li, D.-H., et al. (1994) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)82008-8 · Cited by 13
CP-115,953 stimulates cytokine production by lymphocytes
Riesbeck, K., & Forsgren, A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.476 · Cited by 13
A comparison of conventional metaphase analysis of Giemsa-stained chromosomes with multi-colour fluorescence in situ hybridization analysis to detect chromosome aberrations induced by daunomycin
Ellard, S., Toper, S., Stemp, G., Parry, E. M., Wilcox, P., & Parry, J. M. (1996) · Mutagenesis · doi:10.1093/mutage/11.6.537 · Cited by 13
Involvement of DNA topoisomerases and DNA topoisomerase inhibitors in the induction of leukemia cell differentiation
Larsen, A. K. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058969 · Cited by 13
Experimental DNA-Binding and Computer Modelling Studies on an Analogue of the Anti-Tumour Drug Amsacrine
Abraham, Z. H. L., Agbandje, M., Neidle, S., & Acheson, R. M. (1988) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1988.10506501 · Cited by 13
Characterisation of VP-16-induced DNA cleavage in oestrogen-stimulated human breast cancer cells
Epstein, R. J., Smith, P., Watson, J. V., & Bleehen, N. M. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.104 · Cited by 13
Pharmacokinetic Study of High Dose Etoposide Infusion in Patients with Small Cell Lung Cancer
Green, J. A., Tarpey, A. W., & Warenius, H. M. (1988) · Acta Oncologica · doi:10.3109/02841868809094365 · Cited by 13
Topoisomerase II activity in a DNA double-strand break repair deficient Chinese hamster ovary cell line
Warters, R. L., Lyons, B. W., Li, T., & Chen, D. J. (1991) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(91)90008-d · Cited by 13
Bioactivities and Action Mechanisms of Ellipticine Derivatives Reported Prior to 2023
Hou, W., Xu, X., Huang, L., Zhang, Z., Zhou, Z., Wang, J., Ouyang, X., Xin, S., Zhang, Z., Xiong, Y., et al. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202400210 · Cited by 12
Suppression of topoisomerase IIα expression and function in human cells decreases chromosomal radiosensitivity
Terry, S. Y. A., Riches, A., & Bryant, P. E. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.01.003 · Cited by 12
A Screening of a Library of T7 Phage-Displayed Peptide Identifies E2F-4 as an Etoposide-Binding Protein
Takami, M., Takakusagi, Y., Kuramochi, K., Tsukuda, S., Aoki, S., Morohashi, K., Ohta, K., Kobayashi, S. S., Sakaguchi, K., & Sugawara, F. (2011) · Molecules · doi:10.3390/molecules16054278 · Cited by 12
The exclusive use of flow cytometry to evaluate the antibiotic-susceptibility
Soejima, T., Minami, J.-I., & Iwatsuki, K. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.09.003 · Cited by 12
“Ethidium monoazide (EMA) [4–7] is a eukaryotic topoisomerase poison [8,9] used to stain dead eukaryotic cells [10].”
Background
Evaluation of inhibitory effects of benzothiazole and 3-amino-benzothiazolium derivatives on DNA topoisomerase II by molecular modeling studies
Aki, E., Ertan‐Bolelli, T., Taşkın‐Tok, T., Öztürk, Ö., Ataei, S., Özen, Ç., Yıldız, İ., & Yalçın, İ. (2014) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2014.923039 · Cited by 12
Topoisomerase II Is a Cellular Target for Antiproliferative Cobalt Salicylaldoxime Complex
Jayaraju, D., Gopal, Y. N. V., & Kondapi, A. K. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1327 · Cited by 12
The Nuclear Matrix as a Site of Anticancer Drug Action
Fernandes, D., & Catapano, C. V. (1996) · International review of cytology · doi:10.1016/s0074-7696(08)61238-3 · Cited by 12
ATP‐independent DNA topoisomerase II as potential drug target in trypanosomes
Douc‐Rasy, S., Riou, J., Ahomadegbe, J., & RIOU, G. F. (1988) · Biology of the Cell · doi:10.1016/0248-4900(88)90074-3 · Cited by 12
Differential intracellular processing of the anthracycline drug ME2303 in doxorubicin‐sensitive (A2780) and ‐resistant (A2780AD) human ovarian cancer cells as studied with confocal laser scanning microscopy and image analysis
Huxham, I. M., Barlow, A. L., Lewis, A. D., Plumb, J. A., Mairs, R. J., Gaze, M. N., & Workman, P. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590118 · Cited by 12
Effects of adrenalectomy on Ca2 currents and Ca2 channel subunit mRNA expression in hippocampal CA1 neurons of young rats
Karst, H., Werkman, T. R., Struik, M. L., Bosma, A., & Jo�ls, M. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199706)26:2 · Cited by 14
Inhibition of Dna Topoisomerases by Microbial Inhibitors
Suzuki, K., Siddique, T., Nishimura, H., Sekimoto, J., & Uyeda, M. (1998) · Journal of enzyme inhibition · doi:10.3109/14756369809035826 · Cited by 12
Modulation of etoposide cytotoxicity and DNA strand scission in L1210 and 8226 cells by polyamines.
Dorr, R. T., Liddil, J. D., & Gerner, E. W. (1986) · PubMed · Cited by 12
The chemistry of DNA modification by antitumor antibiotics
Fisher, J. F., & Aristoff, P. A. (1988) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9154-7_12 · Cited by 12
DNA-topoisomerases and regulation of cell proliferation
Kafiani, C. A., Bronstein, I. B., Timofeev, A. V., Gromova, I., & Terskikh, V. V. (1986) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(86)90028-2 · Cited by 12
How can iron salts mediate the degradation of nucleos(t) ides by elliptinium acetate via free-radicals?
Dugué, B., & Meunier, B. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91835-2 · Cited by 12
Nucleoid sedimentation analysis of DNA strand breaks induced in cells exposed to DNA intercalating agents
Mattern, M. R., Kerrigan, D., & Pommier, Y. G. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90015-5 · Cited by 12
Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugs.
Rappa, G., Lorico, A., & Sartorelli, A. C. (1992) · PubMed · Cited by 12
Mutagenicity of topoisomerase‐active agents in bacteriophage T4
DeMarini, D. M., & Lawrence, B. K. (1988) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/tcm.1770080506 · Cited by 12
Introduction and Historical Perspective
Forterre, P. (2011) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-0323-4_1 · Cited by 11
Streptomyces Levis ABRIINW111 Inhibits SW480 Cells Growth by Apoptosis Induction
Maragheh, B. F. A., Fatourachi, P., Mohammadi, S. M., Valipour, B., Behtari, M., Dehnad, A., & Charoudeh, H. N. (2018) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2018.076 · Cited by 11
How Do Microbial Pathogens Make CENs?
Sanyal, K. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002463 · Cited by 11
Anti-hepatoma human single-chain Fv antibody and adriamycin conjugates with potent antitumor activity
Chen, L., Liu, Y., Li, Y.-H., Jiang, Y., Xie, P., Zhou, G., & Li, G. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.11.002 · Cited by 11
Synthesis and antitumor activity of camptothecin- 4β-triazolopodophyllotoxin conjugates
Zi, C., Yang, L., Dong, F.-W., Kong, Q., Ding, Z., Zhou, J., Jiang, Z., & Hu, J. (2019) · Natural Product Research · doi:10.1080/14786419.2018.1538223 · Cited by 11
3,6-Disubstituted 1,2,4-Triazolo[3,4-b]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha
Sagredou, S., Dalezis, P., Nikoleousakos, N., Nikolaou, M., Voura, M., Almpanakis, K., Panayiotidis, M. I., Sarli, V., & Trafalis, D. T. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s254856 · Cited by 11
In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line
Hill, J. E., Lawrence, J., Saba, C., Turek, M., Feldhaeusser, B., Coutermarsh‐Ott, S. L., Barber, J. P., Smith, J., & Gogal, R. M. (2014) · Research in Veterinary Science · doi:10.1016/j.rvsc.2014.07.006 · Cited by 11
mRNA expression of topoisomerase II in human tumors and normal tissues
Kim, R., Hirabayashi, N., Nishiyama, M., Yorishima, T., Toge, T., & Okada, K. (1991) · Surgery Today · doi:10.1007/bf02471001 · Cited by 11
Pharmacological Properties of Oral Idarubicin
Robert, J. (1995) · Clinical Drug Investigation · doi:10.2165/00044011-199500092-00003 · Cited by 11
Expression of Drug Resistance Genes in VP‐16 and mAMSA‐selected Human Carcinoma Cells
Matsumoto, Y., Takano, H., Kunishio, K., Nagao, S., & Fojo, T. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01161.x · Cited by 11
Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity
Riou, J., Grondard, L., Naudin, A., & Bailly, C. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00132-j · Cited by 11
Chronic Etoposide Schedules in the Treatment of Non-Hodgkin’s Lymphoma
Hainsworth, J. D., & Greco, F. (1994) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-78350-0_29 · Cited by 11
Comparison of the effects of DNA topoisomerase inhibitors on lymphoblasts from normal and Fanconi anemia donors
Rosselli, F., Duchaud, É., Averbeck, D., & Moustacchi, E. (1994) · Mutation Research Letters · doi:10.1016/0165-7992(94)90076-0 · Cited by 11
Inhibition of Ah (dioxin) receptor transformation by 9-hydroxy ellipticine
Kurl, R. N., DePetrillo, P. B., & Olnes, M. J. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90108-9 · Cited by 11
Evidence for a Role of Topoisomerase II in the Ca2+-Dependent Basal Level Expression of the Rat Prolactin Gene
White, B. A., & Preston, G. M. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-1-40 · Cited by 11
Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia
Stammler, G., Sauerbrey, A., & Volm, M. (1995) · Cancer Letters · doi:10.1016/0304-3835(94)03664-5 · Cited by 11
Chinese Hamster Cell Lines Defective in DNA Repair
Zdzienicka, M. Z., Simons, J. W. I. M., & Lohman, P. H. M. (1989) · Springer eBooks · doi:10.1007/978-1-4684-1327-4_43 · Cited by 11
A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity
Li, Z., Xu, G., & Li, X. (2021) · Cells · doi:10.3390/cells10113138 · Cited by 10
Antitumor agents 294. Novel E-ring-modified camptothecin–4β-anilino-4′-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents
Ye, D., Shi, Q., Leung, C., Kim, S., Park, S., Gullen, E. A., Jiang, Z. L., Zhu, H., Morris-Natschke, S. L., Cheng, Y.-C., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.030 · Cited by 10
Combination of 1,4-naphthoquinone with benzothiazoles had selective algicidal effects against harmful algae
Kwon, H. L., Kim, J., Na, D. H., Byeun, D. H., Wu, Y., Kim, S. W., Jin, E., & Cho, H. (2013) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-013-0284-6 · Cited by 10
Esters of chlorambucil with 2-substituted 1,4-dihydroxy-9,10-anthraquinones as multifunctional anticancer agents
Jin, G. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01229-6 · Cited by 10
DNA Topoisomerase Inhibitors
Macdonald, T. L., Labroli, M. A., & Tepe, J. J. (1999) · Elsevier eBooks · doi:10.1016/b978-0-08-091283-7.00071-0 · Cited by 10
Correlation of frameshift mutagenicity with dna intercalation by CGS 20928A using an in vitro DNA unwinding assay
Mattes, W. B., Kapeghian, J. C., Lasinski, E. R., O'Lone, S. D., Puri, E. C., & Matheson, D. W. (1993) · Environmental and Molecular Mutagenesis · doi:10.1002/em.2850220108 · Cited by 10
Inhibition of Topoisomerase II Does Not Inhibit Transcription of RNA Polymerase I and II Genes
Dunaway, M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.6.2893 · Cited by 10
Etoposide and Teniposide: In Vivo and In Vitro Genotoxic Studies
Larripa, I. B., Carballo, M. A., de Pargament, M. M., & de Vinuesa, M. L. (1992) · Clinical Drug Investigation · doi:10.1007/bf03258413 · Cited by 10
Assembly of transcriptionally active chromatin in vitro: a possible role for topoisomerase II.
To, R. Q., & Kmiec, E. B. (1990) · PubMed · Cited by 10
Biological and biochemical activities of the novel antitumor antibiotic PD 114,759 and related derivatives
Fry, D. W., Shillis, J. L., & Leopold, W. R. (1986) · Investigational New Drugs · doi:10.1007/bf00172009 · Cited by 10
Components of intrinsic drug resistance in the rat hepatoma
Ellis, A. L., Munger, C. E., Bunch, R. T., Woods, K. E., Randolph, J. K., Boise, L., Swerdlow, P. S., Zwelling, L. A., Hinds, M., Yanovich, S., et al. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90296-u · Cited by 10
Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent
Ellis, A. L., Nowak, B. J., Plunkett, W. K., & Zwelling, L. A. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685085 · Cited by 10
Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells
Roberts, D., Lee, T., Parganas, E., Wiggins, L., Yalowich, J. C., & Ashmun, R. A. (1987) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00254563 · Cited by 10
Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities
Pan, Q., Ye, Z., Ye, Z., Zhang, H., Wang, J., Yi, G., Li, Z., Xu, R., Wang, L., Wu, Z., et al. (2025) · BMEMat · doi:10.1002/bmm2.12137 · Cited by 9
Caspase-dependent drug-induced apoptosis is regulated by cell surface sialylation in human B-cell lymphoma
Suzuki, O., Abe, M., & Hashimoto, Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3320 · Cited by 9
Topoisomerase II Inhibitors: Chemical Biology
Rogojina, A. T., Gajewski, S., Bahmed, K., Osheroff, N., & Nitiss, J. L. (2011) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-0323-4_11 · Cited by 9
An Efficient, Microwave-Assisted, One-Pot Synthesis of Dioxolano Quinoline/benzo[h]quinolines as Potent Antibacterial Agents
Naik, H. R. P., Naik, H. S. B., Naik, T. R. R., Lamani, D. S., & Aravinda, T. (2010) · Phosphorus, sulfur, and silicon and the related elements · doi:10.1080/10426500902797095 · Cited by 9
New Benzodioxole Compounds from the Root Extract of Astrodaucus persicus.
Goodarzi, S., Hadjiakhoondi, A., Yassa, N., Khanavi, M., & Tofighi, Z. (2016) · PubMed Central · Cited by 9
Phase I and Pharmacokinetic Study of Sequences of the Rebeccamycin Analogue NSC 655649 and Cisplatin in Patients with Advanced Solid Tumors
Ricart, A. D., Hammond, L. A., Kuhn, J. G., Takimoto, C. H. M., Goetz, A. D., Forouzesh, B., Forero, L., Ochoa-Bayona, J. L., Berg, K., Tolcher, A. W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1572 · Cited by 9

Authors: Tewey, K. M., Chen, G. L., Nelson, E. M., & Liu, L. F.
Affiliations: Johns Hopkins University (US)
ORCID: Liu, L F
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1984-07
Volume: 259
Issue: 14
Pages: 9182-9187
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1016/s0021-9258(17)47282-6
OpenAlex: W1514525963
Cited by: 887
References: 39
Citations by year: 2026: 2 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 10 · 2019: 16 · 2018: 9 · 2017: 15 · 2016: 19 · 2015: 14 · 2014: 14 · 2013: 16 · 2012: 14
FWCI: 15.02
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 13270 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
Keywords: topoisomerase II, epipodophyllotoxins, etoposide, doxorubicin, cleavable complex, drug-enzyme interaction, nalidixic acid, DNA gyrase, cytotoxicity mechanism
MeSH terms: Alkaloids, Animals, Antineoplastic Agents, Cattle, DNA, DNA Topoisomerases, Type II, DNA Topoisomerases, Type I, DNA, Viral, Ellipticines, HeLa Cells, Humans, Intercalating Agents, Kinetics, Osmolar Concentration, Plasmids, Protein Binding, Thymus Gland

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks